Related Experiment Video
Updated: Jul 11, 2026

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
Effects of albumin 5% and artificial colloids on clot formation in small infants
T Haas1, A Preinreich, E Oswald
1Department of Anaesthesiology and Intensive Care Medicine, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria. thorsten.haas@i-med.ac.at
Insights
Albumin, gelatine, and hydroxyethyl starch (HES) all impact pediatric coagulation. Gelatine showed fewer adverse hemostatic effects than HES, making it a potential albumin alternative in pediatric fluid replacement.
Area of Science:
- Anesthesiology
- Pediatric Critical Care
- Hematology
Background:
- Albumin is the textbook standard for pediatric fluid replacement, but artificial colloids are commonly used.
- Concerns exist regarding artificial colloids' impact on hemostasis, with inconclusive data for 6% hydroxyethyl starch 130/0.4 (HES) in children and no data for gelatine.
Purpose of the Study:
- To compare the hemostatic effects of albumin 5%, 4% modified gelatine solution, and 6% hydroxyethyl starch 130/0.4 (HES) in pediatric patients undergoing surgery.
Main Methods:
- 42 children (3-15 kg) needing colloid replacement were randomized to receive albumin, gelatine, or HES.
- Standard coagulation tests and rotational thromboelastography (ROTEM) were performed post-administration.
Main Results:
- Routine coagulation tests showed comparable significant changes across all groups.
- Activated partial thromboplastin time increased more with gelatine and HES.
- ROTEM analysis revealed significant impairment in all groups, with HES causing the most pronounced negative effects on coagulation parameters, falling below normal ranges.
Conclusions:
- Gelatine solution may be a preferable alternative to albumin from a hemostatic perspective in pediatric fluid replacement.
- 6% hydroxyethyl starch 130/0.4 demonstrated the most significant adverse effects on the overall coagulation process in children.
Abstract:
Albumin is often cited in textbooks as the gold standard for fluid replacement in paediatrics, but in practice artificial colloids are more frequently used. Although one concern with the use of artificial colloids is their intrinsic action on haemostasis, the available data in children are inconclusive for 6% hydroxyethyl starch 130/0.4 (HES) and no data exist for gelatine solution with respect to coagulation. A total of 42 children (3-15 kg) undergoing surgery and needing colloid replacement were randomly assigned to receive 15 mlxkg(-1) of either albumin 5%, 4% modified gelatine solution or 6% hydroxyethyl starch 130/0.4 solution. Standard coagulation tests and modified thrombelastography (ROTEM) were performed. After colloid administration, routine coagulation test results changed significantly and comparably in all groups, although activated partial thromboplastin time values increased more with gelatine and HES. Coagulation time was unchanged in the children who received albumin or gelatine but other activated modified thrombelastography values were significantly impaired in all groups. After gelatine and after albumin the median clot firmness decreased significantly but remained within the normal range. Following HES, coagulation time increased significantly, and clot formation time, alpha angle, clot firmness, and fibrinogen/fibrin polymerisation were significantly more impaired than for albumin or gelatine, reaching median values below the normal range. From a haemostatic point of view it might be preferable to use gelatine solution as an alternative to albumin; HES showed the greatest effects on the overall coagulation process.
Related Concept Videos
Coagulation
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Colloids and Suspensions
Colloidal precipitates
Drug Distribution: Plasma Protein Binding
Colloids
